IMAGE & DATA ANALYSIS
Every week, Fluofarma's generates over 400 gigabits of raw data. To make the most of HCA experiments, we developed automated software solutions for fast data analysis, quality control and data visualization.
MORE INFORMATION
ASSAY DESIGNS FOR NEW TARGETS
Innovative drug discovery strategies call for new assays and drug testing methodologies. Specialized in High Content Analysis, we have been developing custom cell-based assays and biomarker assays for the past ten years.
MORE INFORMATION
TAILORED READOUTS
Fluofarma maintains a panel of over 100 validated cell-based assays allowing the quantification of key phenotypic and molecular events at the single-cell level. Most of the cellular assays listed below can be transferred to a different biological model, o...
MORE INFORMATION
CELL & TISSUE BIOLOGY
As a cell biology company, our prime focus is to test compounds in physiologically relevant cellular models, to better predict future clinical outcomes. We work with cell lines, primary cells and stem cells to design tissue- and disease-specific in vitro ...
MORE INFORMATION
HIGH-CONTENT ANALYSIS
High-content analysis (HCA) is about extracting maximum information from cell biology experiments, using automated, multiplexed and miniaturized technologies, so as to generate highly-reproducible data, while reducing operating costs and turnaround time.
MORE INFORMATIONNEWS & EVENTMORE NEWS
LIVE-CELLS ANALYSIS
HIGH CONTENT HISTOLOGY
FLUOROMETRIC IMAGING
HIGH CONTENT IMAGING
PREDICTIVE TOXICOLOGY
ONCOLOGY
CARDIOVASCULAR
METABOLIC DISEASES
DERMATOLOGY
Fluofarma
2, rue Robert Escarpit
33 600 Pessac, France
Telephone +33 540 003 060
Contact us
WORLDWIDE PRESENCE
